Alexandria, EGYPT - 25 Jan `21Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo

 

In brief: The study to compare the outcomes of mini punch grafting in patients with resistant stable non-segmental vitiligo already on narrowband ultraviolet B and receiving either no additional medication , systemic mini pulse (high and low dose) steroids, topical superpotent steroids once every other day , or daily tacrolimus ointment .in terms of the extent of repigmentation , frequency of reactivation and side effects.

Ages eligible: 18 Years to 50 Years

Start date: January 25, 2021

Completion date (estimated): August 2022

Location: Alexandria University, Alexandria, Egypt

Status: Active, recruiting

Contact: To learn more about this study, you or your doctor may contact Dr. Maha Alsayed Alrashidy at +201024524412 or mahaalrashidy87@yahoo.com

Please refer to this study by its ClinicalTrials.gov identifier NCT04765826.